Literature DB >> 337176

Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin.

C B Dodrill, A S Troupin.   

Abstract

The "psychotropic" effects of carbamazepine were evaluated with phenytoin (Dilantin) as reference agent in a counterbalanced, crossover study. Forty adult epileptics were given a series of neuropsychologic tests and the MMPI after 4 months on each agent. Most abilities were much the same with either anticonvulsant, but there were fewer errors with carbamazepine on mental tasks requiring attention and problem solving, and some improvement in emotional status was suggested. The findings were consistent with patient reports of improvement in alertness and mental functioning. These results combine with the excellent anticonvulsant properties of carbamazepine to support its use as an anticonvulsant.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 337176     DOI: 10.1212/wnl.27.11.1023

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  The management of epilepsy.

Authors:  R Collacott
Journal:  Occas Pap R Coll Gen Pract       Date:  1990-11

Review 2.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Suicidality in epilepsy and possible effects of antiepileptic drugs.

Authors:  Marco Mula; Gail S Bell; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

Review 4.  Anticonvulsant-induced psychiatric disorders. The role of forced normalisation.

Authors:  M R Trimble
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 5.  Adverse neuropsychiatric effects of anticonvulsant drugs.

Authors:  E H Reynolds; M R Trimble
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.

Authors:  J A Pratt; P Jenner; A L Johnson; S D Shorvon; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

7.  [Effects of carbamazepine on EEG. Neuroendocrinological and psychometric examinations (author's transl)].

Authors:  P Clarenbach; R Wachner; G Lucius; O Kanno; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

Review 8.  Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-02-27

Review 9.  Cognitive and behavioural concerns in epileptic children.

Authors:  S K Tamer
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

10.  Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.

Authors:  G J Macphee; E M McPhail; E Butler; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.